Assuming designed is required, the following results were found.

  • Sanofi and Happify Health solidify collaboration around prescription DTx designed to address mental health in people with MS

    engaging,” said Ofer Leidner, co-founder and president of Happify Health. “Further, our evidence-based digital platform is designed to maximize efficacy, safety and patient engagement at scale, three areas which are difficult to attain with one...

    https://mschristian.org/index.php/blog/sanofi-and-happify-health-solidify-collaboration-around-prescription-dtx-designed-to-address-mental-health-in-people-with-ms
  • Capsule Technologies Launches Next Generation Clinical Computing Hub - P&T Community

    to support multiple clinical workflows, including a compact configuration for mobile workflows.Better usability: With a redesigned, flat, edge-to-edge glossy touchscreen, the Neuron 3 provides a high-resolution screen to optimize readability and...

    https://mschristian.org/index.php/blog/capsule-technologies-launches-next-generation-clinical-computing-hub-p-t-community
  • Prescription digital therapeutics: reimagining disease treatment - STAT

    with researchers, clinicians, and engineers working in tandem to leverage the power of software to treat disease. They are designed so patients can access treatment when and where they need it. Similar to traditional medicines, PDTs are prescribed by...

    https://mschristian.org/index.php/blog/prescription-digital-therapeutics-reimagining-disease-treatment-stat
  • Diagnose and Treatment Disclaimer

    This site is designed to inform and support those with Multiple Sclerosis. It is not a comprehensive medical guide to the disease. This information is taken from many different resources. The writings on this site are not intended to diagnose nor...

    https://mschristian.org/index.php/articles/site-info/7-diagnose-and-treatment-disclaimer
  • Essential Oils: A Potential Way to Ease MS Stress

    and sleep quality in some people. Learn more about how to choose and use essential oils. Essential oils are plant extracts designed to capture the “essence,” or scent, of the original plant. Examples of popular essential oils include: Chamomile Jasmine...

    https://mschristian.org/index.php/blog/essential-oils-a-potential-way-to-ease-ms-stress
  • 'I Have Had My Eyes Gouged': What We Heard This Week

    deter potentially good candidates from a career in medicine. "We don't want anybody using any of these products; they are designed to hook you and to hurt you." -- Jacqueline Fincher, MD, president-elect of the American College of Physicians, refuting...

    https://mschristian.org/index.php/blog/i-have-had-my-eyes-gouged-what-we-heard-this-week
  • A Cheap Biotech Stock Tests a Novel Treatment for Multiple Sclerosis - Barron's

    Amit Bar-On will present results on the first dozen patients treated with Atara’s therapy. The Phase 1 study was primarily designed to test safety, but it also measured the treatment’s effect on the patients’ symptoms. The patients all have a severe...

    https://mschristian.org/index.php/blog/a-cheap-biotech-stock-tests-a-novel-treatment-for-multiple-sclerosis-barron-s
  • UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

    optimistic that allo could be an effective treatment for Alzheimer's. Our precision medicine approach for Alzheimer's is designed to treat the right person at the right time. Specifically, our clinical trial of allo will focus on those with early-stage...

    https://mschristian.org/index.php/blog/ua-receives-37-5-million-nih-grant-to-research-potential-regenerative-therapy-for-alzheimer-s
  • Atara Biotherapeutics Announces Third Quarter 2019 Financial Results and Recent Clinical, Operational and Strategic Progress - BioSpace

    autologous CAR T (ATA2271) for patients with advanced mesothelioma with an IND planned in 2020 -- ATA2271 is designed using a novel 1XX CAR co-stimulatory domain and PD-1 dominant negative receptor (DNR) intrinsic checkpoint inhibition technology Atara...

    https://mschristian.org/index.php/blog/atara-biotherapeutics-announces-third-quarter-2019-financial-results-and-recent-clinical-operational-and-strategic-progress-biospace
  • A molecular key for delaying the progression of Multiple Sclerosis is found

    deer. The infectious, misfolded protein... read more July 6, 2018 — A team of engineers has developed a prototype bandage designed to actively monitor the condition of chronic wounds and deliver appropriate drug treatments to improve the chances of...

    https://mschristian.org/index.php/blog/a-molecular-key-for-delaying-the-progression-of-multiple-sclerosis-is-found
  • Study sheds light on brain cell changes in people with MS

    In people with MS, this process does not work as well as in healthy people. Many treatments under development for MS are designed to target oligodendrocytes in the hope of boosting myelin repair. Studies with mice had previously identified several types...

    https://mschristian.org/index.php/blog/study-sheds-light-on-brain-cell-changes-in-people-with-ms
  • What causes numbness and tingling?

    may involve a short round of corticosteroids, which also quickens recovery by reducing inflammation. Several medications designed to treat different conditions may also help reduce numbness and tingling associated with MS, such as: gabapentin pregabalin...

    https://mschristian.org/index.php/blog/what-causes-numbness-and-tingling

Results 1 - 12 of 12
 
 

Follow Us on Twitter

Follow Us On Twitter - Image